These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3560134)

  • 1. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Mikhailidis DP; Barradas MA; Dandona P
    J R Soc Med; 1987 Jan; 80(1):61. PubMed ID: 3560134
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Way BP; Ball MJ; Thorogood M; Cobbe SM; Mann JI
    J R Soc Med; 1986 Jul; 79(7):391-4. PubMed ID: 3746800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk.
    Vuorio A; Watts GF; Kovanen PT
    J Intern Med; 2020 Jun; 287(6):746-747. PubMed ID: 32242993
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia.
    Pedro-Botet J; Climent E; Gabarró N; Millán J
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():43-49. PubMed ID: 34006353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study.
    Mundal L; Veierød MB; Halvorsen T; Holven KB; Ose L; Iversen PO; Tell GS; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2016 Dec; 23(18):1962-1969. PubMed ID: 27558979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice.
    Garg A; Garg V; Hegele RA; Lewis GF
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):880-886. PubMed ID: 31445954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.
    Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž
    Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease.
    Thompson GR
    Atheroscler Suppl; 2013 Jan; 14(1):67-70. PubMed ID: 23357143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.
    van der Graaf A; Kastelein JJP; Wiegman A
    J Inherit Metab Dis; 2009 Dec; 32(6):699. PubMed ID: 19898954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musculoskeletal manifestations in hyperlipidaemia: a controlled study.
    Klemp P; Halland AM; Majoos FL; Steyn K
    Ann Rheum Dis; 1993 Jan; 52(1):44-8. PubMed ID: 8427513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
    Elis A; Zhou R; Stein EA
    Cardiol Young; 2014 Jun; 24(3):437-41. PubMed ID: 23659280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia and cardiovascular disease a top concern for women.
    Gish BA
    Nurs Womens Health; 2009 Feb; 13(1):30-7. PubMed ID: 19207502
    [No Abstract]   [Full Text] [Related]  

  • 17. Cadiovascular complications of homozygous familial hypercholesterolaemia.
    Allen JM; Thompson GR; Myant NB; Steiner R; Oakley CM
    Br Heart J; 1980 Oct; 44(4):361-8. PubMed ID: 7426196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk stratification in familial hypercholesterolaemia.
    Sharifi M; Rakhit RD; Humphries SE; Nair D
    Heart; 2016 Jul; 102(13):1003-8. PubMed ID: 27126396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatic manifestations in patients with hyperlipidemia].
    Menkes CJ
    Presse Med; 1990 Jun; 19(26):1218-20. PubMed ID: 2142769
    [No Abstract]   [Full Text] [Related]  

  • 20. Microalbuminuria is not associated with cardiovascular disease in patients with homozygous familial hypercholesterolaemia.
    Zouvanis M; Raal FJ; Joffe BI; Seftel HC
    Atherosclerosis; 1995 Mar; 113(2):289-92. PubMed ID: 7605367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.